Itonaga, Shuichi
Hamada, Shohei
Ihara, Eikichi
Honma, Hitoshi
Fukuya, Hiroki
Ookubo, Akito
Sasaki, Taisuke
Yoshimura, Daisuke
Nakamuta, Makoto
Sumida, Yorinobu
Harada, Naohiko
Article History
Received: 7 April 2023
Accepted: 16 July 2023
First Online: 24 July 2023
Declarations
:
: The need for informed consent as for this study was waived by the ethics committee Review Board of Clinical Research Institute, National Hospital Organization Kyushu Medical Center, because of the retrospective nature of study. However, all methods (SEMS placement, colonoscopy and endoscopic resection) were performed in accordance with the “Japanese Society for Cancer of the Colon and Rectum: JSCCR Guideline 2022 for the Treatment of Colorectal Cancer”, and “Evidence-based Clinical practice Guidelines for Colonic Polyp 2020” for the Treatment of Colorectal Cancer. In addition, all experimental protocols were based on Declaration of Helsinki, and were approved by the ethics committee Review Board of Clinical Research Institute, National Hospital Organization Kyushu Medical Center.
: Not applicable.
: None of the authors has any Conflict of Interest regarding this report. The datasets generated during and analyzed during the current study are not publicly available due to due to restrictions for the availability of these data, which were used under the license for the current study but are available from the corresponding author on reasonable request. All treating or diagnostic methods for colorectal cancers and other neoplastic lesions were carried out in accordance with “Japanese Society for Cancer of the Colon and Rectum: JSCCR Guideline 2022 for the Treatment of Colorectal Cancer”, and “Evidence-based Clinical practice Guidelines for Colonic Polyp 2020”.